Advanced Biomed Inc. (ADVB) Financial Statements
Advanced Biomed Inc. (ADVB) reported trailing twelve-month revenue of $127637 and net income of $6.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ADVBAdvanced Biomed Inc.Follow ADVB — free
—
Price chart with a free account
- Market cap
- 5.2M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2026 Jun 26 | TTM Jun 26 | Trend |
|---|---|---|---|
| Revenue | 0.1 | — | |
| Operating income | -6.2 | — | |
| Pre-tax income | -6.3 | -6.4 | |
| Income tax | -0.0 | — | |
| Net income | 6.7 | 6.7 | |
| Diluted EPS ($) | 5.33 | 0.03 | |
| Diluted shares (mn) | 1.3 | — |
USD millions · SEC XBRL
Advanced Biomed Inc. — questions
- What is Advanced Biomed Inc.'s revenue?
- $127637 over the twelve months to 2026-06-30, from its 10-Q and 10-K filings.
- What is Advanced Biomed Inc.'s net income?
- $6.7M over the twelve months to 2026-06-30.
- What are Advanced Biomed Inc.'s diluted earnings per share?
- $0.03 over the twelve months to 2026-06-30.
Every figure on this page comes from Advanced Biomed Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.